spectrum beta lactamase
<p>Multilocus sequence typing and <em>bla</em><sub>ESBL</sub> characterization of extended-spectrum beta-lactamase-producing <em>Escherichia coli</em> isolated from healthy humans and swine in Northern Thailand</p>
... to beta-lactam antibiotics expres- sing extended-spectrum beta-lactamase (ESBL) ...extended-spectrum beta-lactamase-producing ...
14
Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal
... extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, ...
7
Diagnostic Validity of Cica Beta Test 1 for the Detection of Extended Spectrum Beta Lactamase (ESBL) Producing Gram Negative Bacteria by Comparing with Phenotypic Method
... extended spectrum beta lactamase producing bacteria is an important issue in the clinical ...Cica Beta Test 1 for detection of extended spectrum beta-lactamase (ESBL) ...
10
Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria
... Extended-spectrum beta-lactamases are enzymes hydrolyzing the beta lactam antibiotics, including third generation cephalosporins and monobactams but not cephamycins and carbapen- ...
7
The Frequency of Extended Spectrum Beta Lactamase (ESBL) in Escherichia coli and Klebsiella pneumoniae: A Report from Mashhad, Iran
... of beta- lactam antibiotics such as penicillins, cephalosporins, monobactams and carbapenems for treatment of patients infected with bacterial infections (2, ...3). Beta-lactamases according to the type of ...
8
Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria
... 23. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS 2nd, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA, AMERECUS Investigators: ...
6
High incidence of antimicrobial resistant organisms including extended spectrum beta lactamase producing Enterobacteriaceae and methicillin resistant Staphylococcus aureusin nasopharyngeal and blood isolates of HIV infected children from Cape Town, South Africa
... Extended spectrum beta-lactamase (ESBL) production was detected using the double disc diffusion test, by placing a disc with amoxicillin/clavulanate adja- cent to discs with cefotaxime and ...
10
Clinical profiles of patients colonized or infected with extended spectrum beta lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital
... Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Ho[r] ...
10
Fecal microbiota transplantation against intestinal colonization by extended spectrum beta lactamase producing Enterobacteriaceae: a proof of principle study
... extended spectrum beta lactamase (ESBL) genes in Enterobacteriaceae leads to delayed effective treatment of infections with these multire- sistant microorganisms, which is associated with higher ...
6
Prevalence and antimicrobial susceptibility patterns of extended spectrum beta lactamase producing Entrobacteriaceae in the University of Gondar Referral Hospital environments, northwest Ethiopia
... extended spectrum beta-lactamase production has been observed mostly in Entrobacteriaceae, and their resistance increased mainly due to the spreading of ESBL and the emergence of different genes ...
7
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms
... Background: Infections caused by multiply drug resistant organisms such as extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae are increasing. Carbapenems ...
5
A comparative study of ciprofloxacin resistance in extended spectrum beta-lactamase and non- extended spectrum beta-lactamase producing enterobacteriaceae in a tertiary care hospital
... infections. Beta- lactams and fluoroquinolone antimicrobial agents are most commonly used as treatment of these bacterial ...Extended- spectrum beta-lactamases (ESBLs) produced by the organisms help ...
9
Prevalance of extended spectrum beta lactamase producing uropathogenic eschereria coli and antimicrobial susceptibility pattern in a tertiarycare hospital in North India
... Urinary tract infections (UTIs) remain the common infections in outpatients as well as Lactamase producing organisms causing urinary tract UTI) are increasing in incidence and pose a major burden to health care. ...
5
Evaluation of The Effect of Antimicrobial Activity of Ethanol Extract of Calotropis Procera in Extended Spectrum Beta- Lactamase Producing E. Coli
... 2. Badal R.E, Bouchillon S.K, Lob S.H, Hackel M.A, Hawser S.P, Hoban D.J. (2013). Etiology, Extended-spectrum β-lactamase Rates and Antimicrobial Susceptibility of Gram-negative Bacilli Causing ...
5
Prevalence of extended-spectrum beta-lactamase-producing bacteria in food
... Abstract: Extended-spectrum b-lactamase (ESBL)-producing Enterobacteriaceae with Cefotaximase–München (CTX-M) enzymes are rapidly increasing worldwide and pose a threat to health care. ESBLs with CTX-M ...
5
Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae
... Piperacillin/tazobactam is the most commonly used broad-spectrum antibiotic in our region (data not shown). Our study suggests a poorer prognosis experi- enced by patients treated with this agent and this has been ...
7
Randomized controlled trial of piperacillin tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended spectrum beta lactamase producing Escherichia coli
... Currently, the most frequently mentioned alternative treatments are beta-lactam/beta-lactamase inhibitors (BLBLI), cephamycins, cefepime, and aminoglycosides [10 – 20]. Results have been promising, ...
9
<em>bla</em><sub>CTX-M-I</sub> group extended spectrum beta lactamase-producing <em>Salmonella typhi</em> from hospitalized patients in Lagos, Nigeria
... bla CTX-M-I across the different regions and countries of the world. Their active roles for dissemination of cefotaxime resistance appear to vary according to geographical region, reservoir of Salmonella isolates (ie, ...
8
A study on Prevalence of extended spectrum Beta lactamase and Amp C Beta lactamase production among escherichia coli and Klebsiella isolated in Urinary Tract Infection.
... the present study, no resistance was noticed to Imipenam. Imipenam should be used as the second line of drug to prevent further resistance and rest of the drugs can be used as the first line of choice. The routine ...
104
Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital, Uganda
... extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in clinical samples of patients in various wards of Mulago Hospital; Uganda ’ s main national referral and teaching ...
6